Surface Oncology   Report issue

For profit Phase 1 Phase 2
Founded: Cambridge MA United States (2014)
Status: Acquired by Coherus BioSciences (2023)

Organization Overview

First Clinical Trial
2018
NCT03512340
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Surface Oncology